JP
FOLD

John Paulson’s Amicus Therapeutics FOLD Stock Holding History

John Paulson’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-32,400
Closed -$469K – 10
2026
Q1 		$469K Buy
+32,400
New +$464K 0.02% 9

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

John Paulson's FOLD Position: Q2 2026 in Review

John Paulson sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 32,400 shares — an estimated $469K sold.

John Paulson first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $469K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • John Paulson reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • John Paulson sold 32,400 Amicus Therapeutics shares in Q2 2026, an estimated $469K.
  • John Paulson first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
  • John Paulson's Amicus Therapeutics position peaked at $469K in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Paulson & Co's 13F filing for Q2 2026, filed 14 Aug 2026.